Clinical Trials Browser

Phase NA × Pancreatic Neoplasms × Docetaxel × Clear all

NCT00159471 2014-05-22

Genes as Predictors of Response to Gemcitabine, Docetaxel, and Capecitabine (GTX) in Metastatic or Unresectable Pancreatic Cancer.

Phase NA Terminated

Gastrointestinal

Pancreatic Neoplasms